STOCK TITAN
  1. Home
  2. THMAU

PEAR THERAPEUTICS (THMAU) Stock Price, News & Analysis

THMAU NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
0 172 sessions, February 2, 2021 to November 30, 2021
Largest daily move
-2.9% close of November 30, 2021

Company Description

THMAU has declined 4.2% over the past month. The last closing price was $9.90.

This page collects what Stock Titan holds for THMAU, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-4.2%
Performance 1 month
-
Market Cap
-
Shares outstanding

PEAR THERAPEUTICS (THMAU) closed at $9.90 on November 30, 2021. Over the past month, the price has lost 4.2%.

See what a $1,000 investment in THMAU would be worth today

THMAU Metrics & Rankings

Month to date
-4.2%
View ranking

Price returns through November 30, 2021. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All
—

Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company

-0.58%

Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference

conferences
-0.38%

Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

fda approval
+0.10%

Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance

+0.10%

Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan

0.00%

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List

0.00%

Pear Therapeutics to Participate in the BTIG Digital Health Forum

conferences
+0.15%

Pear Therapeutics and Thimble Point Acquisition Corp. Announce Effectiveness of S-4 Registration Statement and Set November 23, 2021 for Thimble Point Special Stockholder Meeting to Vote on Proposed Business Combination

acquisition
-0.50%

Thimble Point Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants, Commencing on or About March 25, 2021

acquisition
+0.39%

Thimble Point Acquisition Corp. Announces Closing of Upsized $276 Million Initial Public Offering

IPO offering acquisition

PEAR THERAPEUTICS has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, fda approval, acquisition, IPO, offering. View all THMAU news →

SEC Filings

View All

No SEC filings available for THMAU.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the current quoted price of PEAR THERAPEUTICS (THMAU)?

The current quoted price of PEAR THERAPEUTICS (THMAU) is $9.9 as of November 30, 2021.